Amlodipine and Blindness cortical - a phase IV clinical study of FDA data

Summary:

Blindness cortical is reported as a side effect among people who take Amlodipine (amlodipine besylate), especially for people who are female, 40-49 old, also take Escitalopram, and have Hypokalemia.

The phase IV clinical study analyzes which people have Blindness cortical when taking Amlodipine. It is created by eHealthMe based on reports of 346,875 people who have side effects when taking Amlodipine from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Blindness cortical?

Blindness cortical is found to be associated with 98 drugs and 176 conditions by eHealthMe. Check the latest studies of Blindness cortical.

On Jul, 15, 2026

346,875 people reported to have side effects when taking Amlodipine.
Among them, 23 people (0.01%) have Blindness cortical.

Could Amlodipine cause Blindness cortical?

Among these 23 people:

What is the gender of people who have Blindness cortical when taking Amlodipine? *

female: 85 %
male: 15 %

What is the age of people who have Blindness cortical when taking Amlodipine? *

What are other drugs people take besides Amlodipine? *

Escitalopram: 19 people, 82.61%
Insulin: 15 people, 65.22%
Activated Charcoal: 5 people, 21.74%
Risperidone: 3 people, 13.04%
Vasopressin: 3 people, 13.04%
Glucagon: 3 people, 13.04%
Potassium Chloride: 3 people, 13.04%
Calcium Gluconate: 3 people, 13.04%
Epinephrine: 3 people, 13.04%
Norepinephrine Bitartrate: 2 people, 8.70%

What are other side effects people have besides Blindness cortical? *

Hypotension (abnormally low blood pressure): 20 people, 86.96%
Visual Impairment: 20 people, 86.96%
Anuria (failure of the kidneys to produce urine): 19 people, 82.61%
Cytotoxic Oedema (swelling from being toxic to cells matrials): 19 people, 82.61%
Retinal Ischaemia (lack of blood supply to retina): 19 people, 82.61%
Depressed Level Of Consciousness: 19 people, 82.61%
Pulmonary Oedema (fluid accumulation in the lungs): 19 people, 82.61%
Arrhythmias (irregular heartbeat): 19 people, 82.61%
Embolism Arterial (blood clot that has travelled through your arteries and become stuck): 19 people, 82.61%
Optic Atrophy (the loss of a proportion of optic disc nerve fibres): 19 people, 82.61%

What are the existing conditions these people have? *

Hypokalemia (low potassium): 3 people, 13.04%
General Anaesthesia: 1 person, 4.35%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 4.35%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and have Blindness cortical?

- Check whether Blindness cortical is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amlodipine:

Amlodipine (354,829 reports)

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Blindness cortical:

Blindness cortical (98 drugs)

Browse all the conditions that are associated with Blindness cortical:

Blindness cortical (176 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate (the active ingredients of Amlodipine) and Amlodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.